Status of Government-Funded Radiotherapy Services in Nigeria
Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more...
Saved in:
Published in | JCO global oncology Vol. 9; no. 9; p. e2200406 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health
01.06.2023
American Society of Clinical Oncology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more than 206 million, Nigeria requires a minimum of 280 RT machines for the increasing number of cancer cases. Painfully, the country has only eight Government-funded RT machines. This study aimed to evaluate the status of the eight Government-funded RT services in Nigeria and their ability to deliver effective RT to their patients.
A survey addressing 10 critical areas was used to assess the eight Government-funded RT services in Nigeria.
Unfortunately, six of the eight centers (75%) surveyed have not treated patients with RT because they do not have functioning teletherapy machines in 2021. Only two RT centers have the capability of treating patients using advanced RT techniques. There is no positron emission tomography-computed tomography scan in any of the Government-funded RT centers. The workforce capacity and infrastructure across the eight centers are limited. All of the centers lack residency training programs for medical physicists and radiation therapy technologists resulting in very few well-trained staff.
As the Nigerian Government plans for the new National Cancer Control Plan, there is an urgent need to scale up access to RT by upgrading the RT equipment, workforce, and infrastructure to meet the current needs of Nigerian patients with cancer. Although the shortfall is apparent from a variety of RT-capacity databases, this detailed analysis provides essential information for an implementation plan involving solutions from within Nigeria and with global partners. |
---|---|
AbstractList | PURPOSE
Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more than 206 million, Nigeria requires a minimum of 280 RT machines for the increasing number of cancer cases. Painfully, the country has only eight Government-funded RT machines. This study aimed to evaluate the status of the eight Government-funded RT services in Nigeria and their ability to deliver effective RT to their patients.
METHODS
A survey addressing 10 critical areas was used to assess the eight Government-funded RT services in Nigeria.
RESULTS
Unfortunately, six of the eight centers (75%) surveyed have not treated patients with RT because they do not have functioning teletherapy machines in 2021. Only two RT centers have the capability of treating patients using advanced RT techniques. There is no positron emission tomography-computed tomography scan in any of the Government-funded RT centers. The workforce capacity and infrastructure across the eight centers are limited. All of the centers lack residency training programs for medical physicists and radiation therapy technologists resulting in very few well-trained staff.
CONCLUSION
As the Nigerian Government plans for the new National Cancer Control Plan, there is an urgent need to scale up access to RT by upgrading the RT equipment, workforce, and infrastructure to meet the current needs of Nigerian patients with cancer. Although the shortfall is apparent from a variety of RT-capacity databases, this detailed analysis provides essential information for an implementation plan involving solutions from within Nigeria and with global partners.
Nigeria has the highest burden of cancer in SSA. What is the state of access to radiotherapy in this population? Nigeria has the highest burden of cancer in SSA. What is the state of access to radiotherapy in this population? Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more than 206 million, Nigeria requires a minimum of 280 RT machines for the increasing number of cancer cases. Painfully, the country has only eight Government-funded RT machines. This study aimed to evaluate the status of the eight Government-funded RT services in Nigeria and their ability to deliver effective RT to their patients.PURPOSEAccess to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more than 206 million, Nigeria requires a minimum of 280 RT machines for the increasing number of cancer cases. Painfully, the country has only eight Government-funded RT machines. This study aimed to evaluate the status of the eight Government-funded RT services in Nigeria and their ability to deliver effective RT to their patients.A survey addressing 10 critical areas was used to assess the eight Government-funded RT services in Nigeria.METHODSA survey addressing 10 critical areas was used to assess the eight Government-funded RT services in Nigeria.Unfortunately, six of the eight centers (75%) surveyed have not treated patients with RT because they do not have functioning teletherapy machines in 2021. Only two RT centers have the capability of treating patients using advanced RT techniques. There is no positron emission tomography-computed tomography scan in any of the Government-funded RT centers. The workforce capacity and infrastructure across the eight centers are limited. All of the centers lack residency training programs for medical physicists and radiation therapy technologists resulting in very few well-trained staff.RESULTSUnfortunately, six of the eight centers (75%) surveyed have not treated patients with RT because they do not have functioning teletherapy machines in 2021. Only two RT centers have the capability of treating patients using advanced RT techniques. There is no positron emission tomography-computed tomography scan in any of the Government-funded RT centers. The workforce capacity and infrastructure across the eight centers are limited. All of the centers lack residency training programs for medical physicists and radiation therapy technologists resulting in very few well-trained staff.As the Nigerian Government plans for the new National Cancer Control Plan, there is an urgent need to scale up access to RT by upgrading the RT equipment, workforce, and infrastructure to meet the current needs of Nigerian patients with cancer. Although the shortfall is apparent from a variety of RT-capacity databases, this detailed analysis provides essential information for an implementation plan involving solutions from within Nigeria and with global partners.CONCLUSIONAs the Nigerian Government plans for the new National Cancer Control Plan, there is an urgent need to scale up access to RT by upgrading the RT equipment, workforce, and infrastructure to meet the current needs of Nigerian patients with cancer. Although the shortfall is apparent from a variety of RT-capacity databases, this detailed analysis provides essential information for an implementation plan involving solutions from within Nigeria and with global partners. Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more than 206 million, Nigeria requires a minimum of 280 RT machines for the increasing number of cancer cases. Painfully, the country has only eight Government-funded RT machines. This study aimed to evaluate the status of the eight Government-funded RT services in Nigeria and their ability to deliver effective RT to their patients. A survey addressing 10 critical areas was used to assess the eight Government-funded RT services in Nigeria. Unfortunately, six of the eight centers (75%) surveyed have not treated patients with RT because they do not have functioning teletherapy machines in 2021. Only two RT centers have the capability of treating patients using advanced RT techniques. There is no positron emission tomography-computed tomography scan in any of the Government-funded RT centers. The workforce capacity and infrastructure across the eight centers are limited. All of the centers lack residency training programs for medical physicists and radiation therapy technologists resulting in very few well-trained staff. As the Nigerian Government plans for the new National Cancer Control Plan, there is an urgent need to scale up access to RT by upgrading the RT equipment, workforce, and infrastructure to meet the current needs of Nigerian patients with cancer. Although the shortfall is apparent from a variety of RT-capacity databases, this detailed analysis provides essential information for an implementation plan involving solutions from within Nigeria and with global partners. PURPOSEAccess to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or palliative RT services in Africa, arguably <15% of these patients currently have access to this important service. For a population of more than 206 million, Nigeria requires a minimum of 280 RT machines for the increasing number of cancer cases. Painfully, the country has only eight Government-funded RT machines. This study aimed to evaluate the status of the eight Government-funded RT services in Nigeria and their ability to deliver effective RT to their patients.METHODSA survey addressing 10 critical areas was used to assess the eight Government-funded RT services in Nigeria.RESULTSUnfortunately, six of the eight centers (75%) surveyed have not treated patients with RT because they do not have functioning teletherapy machines in 2021. Only two RT centers have the capability of treating patients using advanced RT techniques. There is no positron emission tomography-computed tomography scan in any of the Government-funded RT centers. The workforce capacity and infrastructure across the eight centers are limited. All of the centers lack residency training programs for medical physicists and radiation therapy technologists resulting in very few well-trained staff.CONCLUSIONAs the Nigerian Government plans for the new National Cancer Control Plan, there is an urgent need to scale up access to RT by upgrading the RT equipment, workforce, and infrastructure to meet the current needs of Nigerian patients with cancer. Although the shortfall is apparent from a variety of RT-capacity databases, this detailed analysis provides essential information for an implementation plan involving solutions from within Nigeria and with global partners. |
Author | Ahmadu, Oiza T Asogwa, Obinna C Itanyi, Ukamaka Chidebe, Runcie C W Okwor, Vitalis C Adewumi, Alabi Bello, Basheer Bisalla, Awwal Eriba, Lucy O Ali-Gombe, Musa Ahmed, Yusuf A Manjit, Dosanjh Alabi, Suleiman Balogun, Ramatallah A Mutiu, Jimoh A Umar, Aisha A Pistenmaa, David Uba, Fatima Aruah, Simeon C Coleman, C Norman Ugwanyi, Charles Ige, Taofeeq Orjiakor, Tochukwu C Shagaya, Uchechukwu N |
Author_xml | – sequence: 1 givenname: Simeon C orcidid: 0000-0003-0149-1617 surname: Aruah fullname: Aruah, Simeon C organization: College of Medicine, University of Abuja, Gwagwalada, Abuja, Nigeria – sequence: 2 givenname: Runcie C W orcidid: 0000-0002-6025-776X surname: Chidebe fullname: Chidebe, Runcie C W organization: Scripps Gerontology Center, Miami University, Oxford, OH – sequence: 3 givenname: Tochukwu C orcidid: 0000-0001-5379-8915 surname: Orjiakor fullname: Orjiakor, Tochukwu C organization: Department of Psychology, University of Nigeria Nsukka, Enugu, Nigeria – sequence: 4 givenname: Fatima surname: Uba fullname: Uba, Fatima organization: Radiation and Clinical Oncology Department, National Hospital Abuja, Abuja, Nigeria – sequence: 5 givenname: Uchechukwu N surname: Shagaya fullname: Shagaya, Uchechukwu N organization: Radiation Oncology Department, National Hospital Abuja, Abuja, Nigeria – sequence: 6 givenname: Charles surname: Ugwanyi fullname: Ugwanyi, Charles organization: Neurosurgery Department, National Hospital Abuja, Abuja, Nigeria – sequence: 7 givenname: Aisha A surname: Umar fullname: Umar, Aisha A organization: Department of Radiology, National Hospital Abuja, Abuja, Nigeria – sequence: 8 givenname: Taofeeq orcidid: 0000-0002-6583-3770 surname: Ige fullname: Ige, Taofeeq organization: Medical Physics Department, National Hospital Abuja, Abuja, Nigeria – sequence: 9 givenname: Obinna C surname: Asogwa fullname: Asogwa, Obinna C organization: Radiotherapy Department, Asi Ukpo Comprehensive Cancer Center, Calabar, Nigeria – sequence: 10 givenname: Oiza T surname: Ahmadu fullname: Ahmadu, Oiza T organization: Radiation Oncology Department, Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria – sequence: 11 givenname: Musa orcidid: 0000-0002-4431-7777 surname: Ali-Gombe fullname: Ali-Gombe, Musa organization: Department of Radiotherapy and Oncology, Federal Teaching Hospital Gombe, Gombe, Nigeria – sequence: 12 givenname: Alabi surname: Adewumi fullname: Adewumi, Alabi organization: Radiation Oncology Department, Nigeria Sovereign Investment Authority-Lagos University Teaching Hospital (NSIA-LUTH), Lagos, Nigeria – sequence: 13 givenname: Vitalis C surname: Okwor fullname: Okwor, Vitalis C organization: Radiation Oncology Department, University of Nigeria Teaching Hospital (UNTH), Ituku Ozalla, Enugu, Nigeria – sequence: 14 givenname: Jimoh A orcidid: 0000-0002-6383-3961 surname: Mutiu fullname: Mutiu, Jimoh A organization: University of Ibadan/University College Hospital Ibadan, Ibadan, Nigeria – sequence: 15 givenname: Basheer surname: Bello fullname: Bello, Basheer organization: Radiation Oncology Department, Usman Danfodio University Teaching Hospital (UDUTH), Sokoto, Nigeria – sequence: 16 givenname: Lucy O surname: Eriba fullname: Eriba, Lucy O organization: Radiation Oncology Department, University of Benin Teaching Hospital (UBTH), Edo State, Nigeria – sequence: 17 givenname: Yusuf A surname: Ahmed fullname: Ahmed, Yusuf A organization: Nigeria Atomic Energy Commission (NAEC), Abuja, Nigeria – sequence: 18 givenname: Awwal surname: Bisalla fullname: Bisalla, Awwal organization: Nigeria Atomic Energy Commission (NAEC), Abuja, Nigeria – sequence: 19 givenname: Ukamaka surname: Itanyi fullname: Itanyi, Ukamaka organization: Radiology Department, University of Abuja Teaching Hospital (UATH), Gwagwalada, Abuja, Nigeria – sequence: 20 givenname: Ramatallah A surname: Balogun fullname: Balogun, Ramatallah A organization: University of Abuja Teaching Hosiptal (UATH), Gwagwalada, Abuja, Nigeria – sequence: 21 givenname: Suleiman surname: Alabi fullname: Alabi, Suleiman organization: Radiation and Clinical Oncology Department, National Hospital Abuja, Abuja, Nigeria – sequence: 22 givenname: David surname: Pistenmaa fullname: Pistenmaa, David organization: International Cancer Expert Corps (ICEC) Inc, Washington, DC – sequence: 23 givenname: C Norman orcidid: 0000-0003-3121-1663 surname: Coleman fullname: Coleman, C Norman organization: International Cancer Expert Corps (ICEC) Inc, Washington, DC – sequence: 24 givenname: Dosanjh orcidid: 0000-0003-1378-349X surname: Manjit fullname: Manjit, Dosanjh organization: European Centre for Nuclear Research (CERN), Geneva, Switzerland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37348033$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1r3DAQxUVJaT6aU-_Fx0LxVhrJ-oBCKaHZBkIXmvYsZHm0UfBaW8leyH9fZzcJyVxmkB6_N8M7JUdDGpCQD4wuGFD6ZblaACwoFVS-IScgtaq1EezoxXxMzku5o5QCSKUNe0eOueJCU85PyNeb0Y1TqVKolmmHedjgMNaX09BhV_12XUzjLWa3va9uMO-ix1LFofoV15ije0_eBtcXPH_sZ-Tv5Y8_Fz_r69Xy6uL7de2F0GPtXFBUONWG0IBExngXOmg5m5uH0DAlVNDSMSOpkV4xjhSxM3I-irce-Bm5OnC75O7sNseNy_c2uWj3Dymvrctj9D3aANI0AGC88WK20KIViIE3OJfes74dWNup3WDn53Oz619BX_8M8dau084yKowCJWfCp0dCTv8mLKPdxOKx792AaSoWNBgBjdYPZp8PUp9TKRnDsw-j9iE_u1xZALvPb1Z_fLnas_YpLf4flHWXMw |
CitedBy_id | crossref_primary_10_1007_s00520_024_08316_6 |
Cites_doi | 10.1200/JGO.19.11000 10.1200/GO.21.00066 10.1016/j.semradonc.2016.11.011 10.1016/j.clon.2020.11.004 10.1016/S2214-109X(18)30089-5 10.1007/s13187-021-02130-y 10.1016/j.ijrobp.2018.06.023 10.1016/S1470-2045(12)70532-6 10.1200/JGO.19.00286 10.1016/j.clon.2021.05.008 10.1016/j.clon.2014.10.006 10.1016/j.ijrobp.2019.04.033 10.1016/S0936-6555(05)80535-7 10.1016/j.clon.2019.10.010 10.3389/fonc.2020.573036 10.1016/S2589-7500(19)30058-5 10.3332/ecancer.2014.492 10.3332/ecancer.2019.942 10.1016/j.jss.2018.09.021 |
ContentType | Journal Article |
Copyright | 2023 by American Society of Clinical Oncology 2023 American Society of Clinical Oncology |
Copyright_xml | – notice: 2023 by American Society of Clinical Oncology 2023 American Society of Clinical Oncology |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1200/GO.22.00406 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2687-8941 |
ExternalDocumentID | oai_doaj_org_article_f26952229c9c4b3184b4eef35eeee8c2 10_1200_GO_22_00406 37348033 |
Genre | Journal Article |
GroupedDBID | AAAAV AAHPQ AAIQE AASCR ABASU ABDBF ABDIG ABVCZ ACILI ACXJB ADGGA ADHPY ADPDF AFDTB AHQNM AHVBC AINUH AJNWD AJZMW ALMA_UNASSIGNED_HOLDINGS AMJPA AMKUR AMNEI AOHHW DIWNM EBS EEVPB FBNNL FCALG GNXGY GQDEL GROUPED_DOAJ H13 HLJTE IKREB M~E NPM OK1 OPUJH OVD OVDNE OVEED RLZ RPM RUC TEORI TSPGW AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c448t-aaf704a7bff526e113dfd2b31dfdc2f51747f86a196096c713e0eed964063bc23 |
IEDL.DBID | RPM |
ISSN | 2687-8941 |
IngestDate | Fri Oct 04 13:14:40 EDT 2024 Tue Sep 17 21:29:36 EDT 2024 Fri Aug 30 19:47:36 EDT 2024 Fri Aug 23 02:30:21 EDT 2024 Wed Oct 16 00:38:45 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c448t-aaf704a7bff526e113dfd2b31dfdc2f51747f86a196096c713e0eed964063bc23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-1378-349X 0000-0003-3121-1663 0000-0002-6025-776X 0000-0001-5379-8915 0000-0002-6383-3961 0000-0003-0149-1617 0000-0002-6583-3770 0000-0002-4431-7777 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497276/ |
PMID | 37348033 |
PQID | 2829425882 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f26952229c9c4b3184b4eef35eeee8c2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10497276 proquest_miscellaneous_2829425882 crossref_primary_10_1200_GO_22_00406 pubmed_primary_37348033 |
PublicationCentury | 2000 |
PublicationDate | 2023-06-01 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JCO global oncology |
PublicationTitleAlternate | JCO Glob Oncol |
PublicationYear | 2023 |
Publisher | Wolters Kluwer Health American Society of Clinical Oncology |
Publisher_xml | – name: Wolters Kluwer Health – name: American Society of Clinical Oncology |
References | Vatnitsky S (b14) 2008 b12 b11 b13 b15 Federal Ministry of Health (b10) b18 b17 b19 International Agency for Research on Cancer (IARC) (b4) Federal Ministry of Health (b9) b1 b2 b6 b7 b8 International Atomic Energy Agency (IAEA) (b16) National Population Commission (NPC) (b5) b21 b20 b23 b22 b25 b24 Yennurajalingam S (b3) 2019; 5 |
References_xml | – volume: 5 start-page: 1 year: 2019 ident: b3 publication-title: J Glob Oncol doi: 10.1200/JGO.19.11000 contributor: fullname: Yennurajalingam S – ident: b21 doi: 10.1200/GO.21.00066 – volume-title: Division for Human Health: DIRAC (DIrectory of RAdiotherapy Centres) ident: b16 contributor: fullname: International Atomic Energy Agency (IAEA) – ident: b8 doi: 10.1016/j.semradonc.2016.11.011 – volume-title: National Policy on Population for Sustainable Development. NPC Publication 1st ed., Abuja, Nigeria, 2021 ident: b5 contributor: fullname: National Population Commission (NPC) – ident: b22 doi: 10.1016/j.clon.2020.11.004 – ident: b11 doi: 10.1016/S2214-109X(18)30089-5 – volume-title: The Global Cancer Observatory (GCO): Nigeria, 2020 ident: b4 contributor: fullname: International Agency for Research on Cancer (IARC) – ident: b15 doi: 10.1007/s13187-021-02130-y – ident: b24 doi: 10.1016/j.ijrobp.2018.06.023 – ident: b12 doi: 10.1016/S1470-2045(12)70532-6 – ident: b6 doi: 10.1200/JGO.19.00286 – ident: b17 doi: 10.1016/j.clon.2021.05.008 – ident: b7 doi: 10.1016/j.clon.2014.10.006 – ident: b25 doi: 10.1016/j.ijrobp.2019.04.033 – ident: b13 doi: 10.1016/S0936-6555(05)80535-7 – volume-title: Transition From 2-D Radiotherapy to 3-D Conformal and Intensity Modulated Radiotherapy year: 2008 ident: b14 contributor: fullname: Vatnitsky S – ident: b20 doi: 10.1016/j.clon.2019.10.010 – ident: b19 doi: 10.3389/fonc.2020.573036 – ident: b23 doi: 10.1016/S2589-7500(19)30058-5 – volume-title: National Cancer Control Programme ident: b9 contributor: fullname: Federal Ministry of Health – ident: b2 doi: 10.3332/ecancer.2014.492 – ident: b1 doi: 10.3332/ecancer.2019.942 – volume-title: National Cancer Control Plan 2018-2022 ident: b10 contributor: fullname: Federal Ministry of Health – ident: b18 doi: 10.1016/j.jss.2018.09.021 |
SSID | ssj0002267891 |
Score | 2.2896812 |
Snippet | Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially curative or... PURPOSE Access to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially... Nigeria has the highest burden of cancer in SSA. What is the state of access to radiotherapy in this population? PURPOSEAccess to radiotherapy (RT) is now one of the stark examples of global cancer inequities. More than 800,000 new cancer cases require potentially... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e2200406 |
SubjectTerms | ORIGINAL REPORTS |
SummonAdditionalLinks | – databaseName: DOAJ: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8NAEF7Eg3gR38YXEXqNTXaTTQJeVGyL0BbEQm_LPrUeUrHtwX_vTJLWVAQv5pKQBDKZGebBzn4fIS0wuY2o5oFyzECDwuAK8lzgcCIqDZ3MSo6l_oD3RvHjOBk3qL5wJqyCB64U13aU5wmSTutcxwo8MFaxtY4lFo5MV9E3ShrN1FsJ6gJBOI_qDXngCe3u8JoiNmeM3EaNFFQi9f9WXv6ckmyknc4u2anrRf-2knOPbNhin2z16xXxA3KD1eJi5k-d_02bG3Rwa5jxn6SZ1DusPv1lVPAnhT-YvKDnHZJR5-H5vhfUjAiBhjZqHkjp0jCWqXIuodxGETPOUNAKnDR1iDqduozLCHHkuIYG1IaQBHMOf82UpuyIbBbTwp4Q33DNcodMvVzH1CQyTHOrjMkUjRSUJR5pLZUk3ivgC4ENA-hSdIeCUlHq0iN3qMDVK4hWXd4AG4rahuIvG3rkaql-Ad6NSxaysNPFTOA6L0QVaAM8clyZY_UphsA8IWMeydYMtSbL-pNi8loiaEMPmkPhxk__Q_ozso0c9NX82DnZnH8s7AVUKnN1WTrlF_PF5uc priority: 102 providerName: Directory of Open Access Journals |
Title | Status of Government-Funded Radiotherapy Services in Nigeria |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37348033 https://www.proquest.com/docview/2829425882/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC10497276 https://doaj.org/article/f26952229c9c4b3184b4eef35eeee8c2 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB60B-lFfBtfRPCaNtlNNgl40WIVoa2IQm9L9qURTUXbg__e2W2iVjyZS0IeZJkZduZjZr4BOEGV64hIFghDFQIUilfo5wJjK6LS0BSZm7E0GLKr-_h6nIyXgDW9MK5oX4qyUz2_dKry0dVWvr7IblMn1r0Z9BBC5Oh3WXcZllNKf2D0J0foghtwHtXNeGgF3ctRh1heTnRebVihltAlpHTBEznC_r-izN_Fkj-8T38NVuuw0T-bL28dlnS1ASuDOjG-Cac2aJy9-xPjf0_PDfq2Q0z5t4Uq60arD7_ZHPyy8oflgzXALbjvX9z1roJ6MEIgEU1Ng6IwaRgXqTAmIUxHEVVGEUEjPEliLPl0ajJWRJZOjknEoTpEX5gzFAAVktBtaFWTSu-Cr5ikubEDe5mMiUqKMM21UCoTJBIYnXhw0giJv875L7jFDShWfjnihHAnVg_OrQC_XrGk1e7G5O2B16rjhrA8sfPDZS5jXG0Wi1hrQxONRyaJB8eN-Dkauc1cFJWezN65Tffi5oJowIOduTq-ftWo04NsQVELa1l8gnbliLQbO9r7_6f70LYD6OfFYwfQmr7N9CGGKVNx5OD9kbPNT_5-6Co |
link.rule.ids | 230,315,733,786,790,870,891,2115,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BlSgXWmiB0AdB4ppsYidOIvXSoi7bwi6oApWbFb-W8Mgi2D20v75jJ6Es6qXkkihOFMff2DMjz3wDsIeQ65hIFghDFTooFK9QzwXGRkRlkSlzV2NpOGKDs-T7eXq-AKzLhXFB-1JUYX19E9bVhYutvL2RvS5OrHcy3EcXokC9y3qL8AInLEkfeemXjtIFl-AibtPxUA56B8chscycqL5WYJlaSpeI0jld5Cj7_2VnPg2XfKR_-q_gZ9fzJuzkKpxNRSh_PyF1_P9few2rrUnqf27a12BB1-uwPGw33d_AJ2uQzu79ifH_VuYN-jb7TPk_SlW1SVy__G7h8avaH1VjK9xv4az_9XR_ELRFFwKJnto0KEuTRUmZCWNSwnQcU2UUETTGkyTGEltnJmdlbKnqmEQfV0eoZwuGQ0uFJHQDlupJrbfAV0zSwthiwEwmRKVllBVaKJULEgu0fDzY64af3zbcGtz6JAgYPzjmhHAHmAdfLDQPj1hCbHdjcjfm7dhxQ1iR2trkspAJ9jZPRKK1oanGI5fEg90OWI4TyO6KlLWezO653UrGhQs9DQ82G6AfPtUJigf5nAjM9WW-BYF1JN0dkNvPf3UHXg5Oh0f86Nvo8B2s2EL3TZDae1ia3s30BzSHpuKjk_0_nhsJbw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTtxAEC2FiTTiQsgCcVZH4uqt227bUi4EMpDADAiBhJRDy70Rs3hGsxzg66n2QhiUE77Y8iK3-5W7qtSvXwFsIeQ6IpJ5wlCFCQrFI_RznrGMqDQ0RVbXWBqO2P5Z_Ps8OW9ZlbOWVllJUfrV9Y1flX9rbuXkRgYdTyw4Hu5gCpGj32XBRJlgBV7iT0vSR5n6ZS3rgsNwHrVL8tAWgr0jn1h1TnRhq9CnVtYlpHTJH9Wy_f-LNZ9SJh_5oMEr-NO1vqGeXPmLufDl3RNhx-d93jqstaGpu93c8xpe6OoN9Ift5Ptb-G4D08XMHRv3X4Veb2BXoSn3pFBlu5jr1u0GILes3FF5YY38HZwNfp7u7Htt8QVPYsY294rCpGFcpMKYhDAdRVQZRQSNcCeJsQLXqclYEVnJOiYx19Uh-tucYfdSIQndgF41rvR7cBWTNDe2KDCTMVFJEaa5FkplgkQCIyAHtjoI-KTR2OA2N0HQ-N4RJ4TXoDnww8LzcIsVxq5PjKcXvO0_bgjLE1ujXOYyxtZmsYi1NjTRuGWSOPCtA5fjj2RnR4pKjxczbqeUcQDDjMOBzQbsh1d1xuJAtmQGS21ZvoLg1mLdHZgfnv_oV-gf7w744a_RwUdYtfXuG67aJ-jNpwv9GaOiufhSm_899bYL7w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Status+of+Government-Funded+Radiotherapy+Services+in+Nigeria&rft.jtitle=JCO+global+oncology&rft.au=Aruah%2C+Simeon+C.&rft.au=Chidebe%2C+Runcie+C.W.&rft.au=Orjiakor%2C+Tochukwu+C.&rft.au=Uba%2C+Fatima&rft.date=2023-06-01&rft.issn=2687-8941&rft.eissn=2687-8941&rft.issue=9&rft_id=info:doi/10.1200%2FGO.22.00406&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_GO_22_00406 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2687-8941&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2687-8941&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2687-8941&client=summon |